Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Drew Fischer is a corporate associate in the firm’s Washington, DC office. His practice focuses on a broad range of strategic transactions and general corporate matters, including asset and stock acquisitions and divestures, public and private mergers, carve-out acquisitions and divestitures, and cross-border transactions.

Mr. Fischer has experience in a wide range of industries, including the life sciences, defense and government contracting, equipment and manufacturing, and technology industries.

  • Merck in its:
    • $2.7 billion acquisition of ArQule (NASDAQ: ARQL);
    • €2.1 billion acquisition of Antelliq Group, a leader in digital animal identification, traceability and monitoring solutions, the fastest growing part of the animal health industry;
    • $1.05 billion acquisition of Peloton Therapeutics; and
    • acquisition of Themis Bioscience, a SARS-CoV-2 candidate developer.
  • Bacardi in its acquisition of Patrón Spirits International AG and its PATRÓN® brand, the world’s top-selling ultra-premium tequila, from John Paul DeJoria, a founder of Patrón, in a deal valuing the company at $5.1 billion.
  • Astellas in its $3 billion acquisition of gene therapy company Audentes Therapeutics, Inc. (NASDAQ: BOLD).
  • Elbit Systems of America in its $350 million acquisition of the Night Vision business of Harris Corporation.
  • GovernmentCIO LLC in its sale to Welsh Carson Anderson & Stowe.
  • A major multinational technology company in several cross-border acquisitions.
  • Several global companies in internal restructuring matters.

Pro Bono

  • Advised a non-profit organization that is dedicated to assisting immigrant and refugees in adjusting to local communities regarding its formation, its application for obtaining tax exempt status and commercial and general corporate matters.
  • Advised several non-profit organizations regarding acquisitions or contributions of assets.